• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    3/29/23 12:50:58 PM ET
    $AGBA
    $AMBI
    $ANGN
    $ARCT
    Investment Managers
    Finance
    Environmental Services
    Industrials
    Get the next $AGBA alert in real time by email

    Gainers

    • LogicMark, Inc. (NASDAQ:LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.
    • Ambipar Emergency Response (NASDAQ:AMBI) surged 40.9% to $10.95.
    • Local Bounti Corporation (NYSE:LOCL) gained 35% to $0.6102 after the company announced it secured up to $145 million of additional financing to support growth. The company also reported Q4 financial results and issued guidance.
    • WaveDancer, Inc. (NASDAQ:WAVD) jumped 30% to $0.3450.
    • CBL International Limited (NASDAQ:BANL) surged 26.8% to $8.64.
    • Kodiak Sciences Inc. (NASDAQ:KOD) gained 18.3% to $5.80 after posting a narrower-than-expected quarterly loss.
    • Helbiz, Inc. (NASDAQ:HLBZ) gained 16.8% to $0.1343. Helbiz posted FY22 revenue of $15.5 million, up 21% year over year.
    • Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) shares climbed 16.5% to $18.05 after the company reported better-than-expected Q4 EPS and sales results.
    • Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) gained 16.3% to $2.14.
    • Bird Global, Inc. (NASDAQ:BRDS) rose 16.2% to $0.2252 after jumping 42% on Tuesday.
    • Erasca, Inc. (NASDAQ:ERAS) gained 15.3% to $3.16. Erasca Chairman & CEO Jonathan Lim acquired a total of 100,000 shares at an average price of $2.84.
    • Lululemon Athletica Inc. (NASDAQ:LULU) shares climbed 15.1% to $368.73 after the company reported better-than-expected Q4 results and issued strong guidance.
    • Atai Life Sciences N.V. (NASDAQ:ATAI) rose 14.6% to $1.5250.
    • Cipher Mining Inc. (NASDAQ:CIFR) gained 13.7% to $2.1604.
    • Tempest Therapeutics, Inc. (NASDAQ:TPST) climbed 13.1% to $1.98. Tempest Therapeutics recently posted a Q4 loss of $0.63 per share.
    • Enovix Corporation (NASDAQ:ENVX) gained 13% to $12.70. The company announced a new manufacturing partner and selected the location for its next high-volume manufacturing facility.
    • N-able, Inc. (NYSE:NABL) shares rose 12.6% to $13.72. N-able will replace iStar Incin the S&P SmallCap 600 on Monday, April 3.
    • Angion Biomedica Corp. (NASDAQ:ANGN) gained 12.5% to $0.54.
    • AST SpaceMobile, Inc. (NASDAQ:ASTS) jumped 11% to $6.24.
    • Riot Platforms, Inc (NASDAQ:RIOT) shares rose 10% to $8.92 amid a rise in Bitcoin.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) shares surged 10% to $7.92 amid a rise in Bitcoin.
    • Stratasys Ltd. (NASDAQ:SSYS) jumped 9.8% to $15.50 after Nano Dimension increased its offer to acquire the company to $19.55 per share in cash.
    • Hut 8 Mining Corp (NASDAQ:HUT) gained 9.4% to $1.7607 amid strength in cryptocurrencies.
    • Cal-Maine Foods, Inc. (NASDAQ:CALM) shares climbed 8.3% to $58.87 after the company reported better-than-expected financial results for its fiscal third quarter.
    • Rivian Automotive, Inc. (NASDAQ:RIVN) climbed 7.9% to $13.98. Needham reiterated Rivian Automotive with a Buy and maintained a $26 price target.
    • Micron Technology, Inc. (NASDAQ:MU) gained 6.2% to $62.99 following fiscal second-quarter financial results.

    Losers

    • ProQR Therapeutics N.V. (NASDAQ:PRQR) fell 32.7% to $2.41. ProQR Therapeutics posted a FY loss of €0.91 per share.
    • bluebird bio, Inc. (NASDAQ:BLUE) dropped 30.6% to $2.9953 after the company reported Q4 and full year 2022 financial results. Also, a Bloomberg report suggesting Bluebird Bio expects a delay on its FDA sickle cell drug application is also impacting the stock.
    • Sharecare, Inc. (NASDAQ:SHCR) shares dipped 27.3% to $1.5486 after the company reported Q4 results.
    • Minim, Inc. (NASDAQ:MINM) fell 24.1% to $0.1088 after reporting Q4 results.
    • Shift Technologies, Inc (NASDAQ:SFT) shares dropped 23.8% to $1.29 after reporting downbeat quarterly sales. Shift also announced regaining compliance with Nasdaq listing requirement.
    • Near Intelligence, Inc. (NASDAQ:NIR) fell 20.8% to $2.85 after the company reported Q4 financial results.
    • Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) dipped 18.2% to $1.21 after the company reported a 17.6% year-over-year decline in revenue in FY22 to $25.9 million.
    • Stem, Inc. (NYSE:STEM) dropped 16.8% to $5.18 after the company announced a proposed $175 million green convertible senior notes offering.
    • AGBA Group Holding Limited (NASDAQ:AGBA) dropped 16.1% to $2.1801.
    • GlycoMimetics, Inc. (NASDAQ:GLYC) fell 15.3% to $1.1850 after posting a wider-than-expected quarterly loss.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) dipped 13.3% to $0.1646.
    • Draganfly Inc. (NASDAQ:DPRO) fell 13.3% to $1.24. Draganfly announced pricing of $8 million underwritten public offering of 8 million shares of common stock at a price of $1 per share to secure growth capital.
    • Gulf Island Fabrication, Inc. (NASDAQ:GIFI) dropped 13.2% to $3.67 following Q4 results.
    • El Pollo Loco Holdings, Inc. (NASDAQ:LOCO) fell 12.9% to $8.97.
    • SomaLogic, Inc. (NASDAQ:SLGC) fell 9.5% to $1.29 after the company posted a wider-than-expected Q4 loss.
    • UniFirst Corporation (NYSE:UNF) dropped 9.3% to $175.14 after posting Q2 results.
    • IceCure Medical Ltd (NASDAQ:ICCM) fell 7.8% to $1.1799 after gaining 14% on Tuesday. IceCure Medical secured regulatory approval in China for commercial use of its IceSense3 Disposable Cryoprobes.

    Now Read This: Bitcoin Surges Past This Key Level; Mask Network, Frax Share Among Top Gainers

    Get the next $AGBA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGBA
    $AMBI
    $ANGN
    $ARCT

    CompanyDatePrice TargetRatingAnalyst
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    Enovix Corporation
    $ENVX
    2/26/2026$15.00 → $7.50Hold
    TD Cowen
    N-able Inc.
    $NABL
    2/20/2026$9.50 → $5.50Market Perform
    BMO Capital Markets
    Rivian Automotive Inc.
    $RIVN
    2/17/2026$14.00Neutral → Underperform
    DA Davidson
    Micron Technology Inc.
    $MU
    2/17/2026$380.00 → $450.00Buy
    Needham
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$23.00Hold → Buy
    Deutsche Bank
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$16.00Sell → Neutral
    UBS
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    More analyst ratings

    $AGBA
    $AMBI
    $ANGN
    $ARCT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Liu Teyin M bought $7,821,723 worth of shares (23,200 units at $337.14), increasing direct ownership by 856% to 25,910 units (SEC Form 4)

    4 - MICRON TECHNOLOGY INC (0000723125) (Issuer)

    1/15/26 7:07:13 PM ET
    $MU
    Semiconductors
    Technology

    Director Larson Keith R bought $50,000 worth of shares (625 units at $80.00) (SEC Form 4)

    4 - AST SpaceMobile, Inc. (0001780312) (Issuer)

    12/29/25 6:00:02 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Director Baker Bros. Advisors Lp bought $60,000,008 worth of shares (2,608,696 units at $23.00) (SEC Form 4)

    4 - Kodiak Sciences Inc. (0001468748) (Issuer)

    12/19/25 4:06:09 PM ET
    $KOD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGBA
    $AMBI
    $ANGN
    $ARCT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGBA
    $AMBI
    $ANGN
    $ARCT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MARA Holdings Inc. downgraded by H.C. Wainwright

    H.C. Wainwright downgraded MARA Holdings Inc. from Buy to Neutral

    2/27/26 11:05:23 AM ET
    $MARA
    EDP Services
    Technology

    TD Cowen reiterated coverage on Enovix with a new price target

    TD Cowen reiterated coverage of Enovix with a rating of Hold and set a new price target of $7.50 from $15.00 previously

    2/26/26 6:56:07 AM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    BMO Capital Markets reiterated coverage on N-able with a new price target

    BMO Capital Markets reiterated coverage of N-able with a rating of Market Perform and set a new price target of $5.50 from $9.50 previously

    2/20/26 7:58:12 AM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    $AGBA
    $AMBI
    $ANGN
    $ARCT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Micron Celebrates Opening of India's First Semiconductor Assembly and Test Facility

    SANAND, India, Feb. 28, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (NASDAQ:MU) today celebrated the grand opening of its semiconductor assembly and test facility in Sanand, Gujarat, India. The state-of-the-art facility converts advanced DRAM and NAND wafers from Micron's global manufacturing network into finished memory and storage products. Once fully ramped, the first phase of Micron's Sanand operation will feature more than 500,000 square feet of cleanroom space, making it one of the world's largest single-floor assembly and test cleanrooms. The site serves customers worldwide to meet the growing global demand for memory and storage fueled by AI. The facility represents a combine

    2/28/26 7:00:00 AM ET
    $MU
    Semiconductors
    Technology

    Draganfly Announces Closing of US$50.0 Million Registered Direct Offering

    Saskatoon, SK., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO) (CSE:DPRO) (FSE: 3U8A) ("Draganfly" or the "Company"), an award-winning developer of drone solutions, software, and robotics, today announced the closing of its previously announced registered direct offering of 7,150,000 common shares (or pre-funded warrants in lieu thereof) of the Company at a price of US$7.00, for gross proceeds of approximately US$50.0 million, before deducting placement agent discounts and offering expenses (the "Offering"). Maxim Group LLC acted as lead placement agent for the Offering. Raymond James Ltd. and Ladenburg Thalmann & Co. Inc. acted as co-placement agents for the Offering. Dr

    2/27/26 4:10:00 PM ET
    $DPRO
    Aerospace
    Industrials

    Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments

    Issued on behalf of Helus PharmaVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity-Insider.com News Commentary -- Psychedelic compounds are edging closer to regulatory approval as pivotal trials in treatment-resistant depression and anxiety advance through late-stage development[1]. The sector is shedding its countercultural reputation as biotech firms reposition serotonergic and psychedelic-derived therapies as mainstream pharmaceutical candidates[2]. Five companies are building the clinical programs to get there: Helus Pharma (NASDAQ:HELP), AtaiBeckley (NASDAQ:ATAI), Definium Therapeutics (NASDAQ:DFTX), GH Research (NASDAQ:GHRS), and LB Pharmaceuticals (NASDAQ:LBRX).

    2/27/26 11:44:00 AM ET
    $ATAI
    $DFTX
    $GHRS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medicinal Chemicals and Botanical Products

    $AGBA
    $AMBI
    $ANGN
    $ARCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Executive Officer Page Tyler

    4 - Cipher Digital Inc. (0001819989) (Issuer)

    2/27/26 5:24:35 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Chief Financial Officer Mumford Gregory J.D.

    4 - Cipher Digital Inc. (0001819989) (Issuer)

    2/27/26 5:23:57 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Co-President and CLO Iwaschuk William

    4 - Cipher Digital Inc. (0001819989) (Issuer)

    2/27/26 5:23:14 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    $AGBA
    $AMBI
    $ANGN
    $ARCT
    SEC Filings

    View All

    SEC Form DEFA14A filed by lululemon athletica inc.

    DEFA14A - lululemon athletica inc. (0001397187) (Filer)

    2/27/26 5:19:59 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    Brainstorm Cell Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits

    8-K - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Filer)

    2/27/26 4:24:56 PM ET
    $BCLI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SUPPL filed by Draganfly Inc.

    SUPPL - Draganfly Inc. (0001786286) (Filer)

    2/27/26 8:13:33 AM ET
    $DPRO
    Aerospace
    Industrials

    $AGBA
    $AMBI
    $ANGN
    $ARCT
    Financials

    Live finance-specific insights

    View All

    MARA Announces Fourth Quarter and Fiscal Year 2025 Results

    Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a leading energy and digital infrastructure company, today announced its preliminary, unaudited fourth quarter and fiscal year 2025 financial results in a letter to shareholders. Investors are invited to access the fourth quarter 2025 shareholder letter at MARA's website at ir.mara.com. A copy of the letter will also be furnished to the Securities and Exchange Commission on a Form 8-K. MARA will hold a webcast and conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) today to discuss these financial results. To register to participate in the conference call, please use

    2/26/26 4:20:00 PM ET
    $MARA
    EDP Services
    Technology

    MARA Announces Strategic Partnership with Starwood to Accelerate Delivery of Cutting Edge Hyperscale, Enterprise and AI Capable Digital Infrastructure

    Joint Platform Expected to Deliver Approximately 1 GW of Near-Term IT Capacity, with Pathway to More than 2.5 GW  Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ:MARA), a leading energy and compute infrastructure company, today announced it has entered into a strategic agreement with Starwood Capital Group ("Starwood") and their dedicated data center development platform Starwood Digital Ventures ("SDV"). The partnership will enable the conversion and expansion of select MARA sites into next generation digital infrastructure capable of meeting the growing demand from enterprise, hyperscale and AI customers. Together, MARA and Starwood will jointly develop, financ

    2/26/26 4:15:00 PM ET
    $MARA
    EDP Services
    Technology

    AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder

    EMP-01 met its primary objective on safety and tolerability, demonstrating a generally favorable and manageable safety and tolerability profileEMP-01 demonstrated a clinically meaningful placebo-adjusted least squares mean reduction of 11.85 points on the Liebowitz Social Anxiety Scale (LSAS) at Day 43 (Hedges' g = 0.45; p-value = 0.036, one-tailed)EMP-01 demonstrated a robust separation from placebo on the Clinician Global Impression–Improvement (CGI-I) assessment: 49% responders vs. 15% for placebo, corresponding to a Number Needed to Treat (NNT) of 2.95EMP-01 demonstrated improvements across both Fear and Avoidance sub-domains of the LSAS, including improvement in social avoidance behavio

    2/26/26 7:00:00 AM ET
    $ATAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AMBI
    $ANGN
    $ARCT
    Leadership Updates

    Live Leadership Updates

    View All

    Chip Wilson Provides Update to lululemon Shareholders

    VANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Chip Wilson, Founder of lululemon athletica inc. (NASDAQ:LULU) ("lululemon" or the "Company") and one of lululemon's largest shareholders, today released the following letter to lululemon shareholders: Shareholders of lululemon:In support of all shareholders, I am pursuing a campaign to catalyze a quantum of change that is sorely needed at lululemon. To effect that change, I have pursued private, constructive dialogues with the lululemon Board of Directors (the "Board") for the past few months. My attempts toward a sensible solution have not been reciprocated.The heart of the issue is a disconnect between the Company's creative engine and the Board's str

    2/27/26 8:00:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    Draganfly Welcomes Lieutenant-General (Ret'd) Michel Gauthier to Military Advisory Board in Support of Canada's Defence Industrial Strategy

    Ottawa, ON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO, CSE:DPRO, FSE: 3U8A)) ("Draganfly" or the "Company"), an award-winning developer of drone solutions, software, and robotics, today announced the appointment of Lieutenant-General (Ret'd) Michel Gauthier to its Military Advisory Board. The appointment comes as Canada advances its renewed Defence Industrial Strategy, a national framework focused on strengthening sovereign defence production, accelerating innovation, modernizing procurement, and reducing reliance on foreign supply chains. Lieutenant-General Gauthier brings more than 36 years of distinguished service with the Canadian Armed Forces. He served as Comman

    2/20/26 8:30:00 AM ET
    $DPRO
    Aerospace
    Industrials

    AtaiBeckley Appoints Michael Faerm as Chief Financial Officer

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc (NASDAQ:ATAI) ("AtaiBeckley" or the "Company"), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced the appointment of Michael Faerm as Chief Financial Officer, effective March 9, 2026. Mr. Faerm is a seasoned financial executive with more than 25 years of experience across life sciences companies, equity research, and investment banking. As Chief Financial Officer at AtaiBeckley, he will lead the Company's financial strategy, capital markets activities, and overall financial operations. Anne Johnson, who ha

    2/19/26 7:00:00 AM ET
    $ATAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AMBI
    $ANGN
    $ARCT
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AMBI
    $ANGN
    $ARCT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Pieris Pharmaceuticals Inc.

    SC 13G/A - PALVELLA THERAPEUTICS, INC. (0001583648) (Subject)

    12/17/24 5:42:35 PM ET
    $PIRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by LogicMark Inc.

    SC 13D/A - LogicMark, Inc. (0001566826) (Subject)

    12/3/24 3:35:39 PM ET
    $LGMK
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by GlycoMimetics Inc.

    SC 13G - GLYCOMIMETICS INC (0001253689) (Subject)

    11/27/24 2:22:44 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care